Cargando…
Prostaglandin D(2) metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP(2) receptor
BACKGROUND: Prostaglandin D(2) (PGD(2)) signaling via prostaglandin D(2) receptor 2 (DP(2)) contributes to atopic and non-atopic asthma. Inhibiting DP(2) has shown therapeutic benefit in certain subsets of asthma patients, improving eosinophilic airway inflammation. PGD(2) metabolites prolong the in...
Autores principales: | Carstensen, Saskia, Gress, Christina, Erpenbeck, Veit J., Kazani, Shamsah D., Hohlfeld, Jens M., Sandham, David A., Müller, Meike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499518/ https://www.ncbi.nlm.nih.gov/pubmed/34620168 http://dx.doi.org/10.1186/s12931-021-01852-3 |
Ejemplares similares
-
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D(2) Production Are Attenuated by PGD(2) Receptor 2 Antagonism
por: Chen, Wentao, et al.
Publicado: (2021) -
The prostaglandin D(2) receptor 2 pathway in asthma: a key player in airway inflammation
por: Domingo, Christian, et al.
Publicado: (2018) -
Type 2 innate lymphoid cells control eosinophil homeostasis
por: Nussbaum, Jesse C., et al.
Publicado: (2013) -
Prostaglandin E(2) suppresses human group 2 innate lymphoid cell function
por: Maric, Jovana, et al.
Publicado: (2018) -
Prostaglandin D(2) (PGD(2)); PGD(2) receptor subtype DP1
Publicado: (2011)